Monocytes, macrophages, and dendritic cells

Wintrobe's Clinical Hematology: Thirteenth Edition

Volumn , Issue , 2013, Pages 193-226

  Collin, Matthew ^a,b   Hughes, Derralynn A ^c   Plüddemann, Annette ^d   Gordon, Siamon ^e  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84976558744     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (135)

1. Beutler B. How mammals sense infection: from endotoxin to the toll-like receptors. Nobel Lectures 2012. http://www.nobelprize.org/nobel_prizes/medicine/laureates/2011/beutler-lecture.html; Accessed on 5 February 2013.
2. Cavaillon JM. The historical milestones in the understanding of leukocyte biology initiated by Elie Metchnikoff. J Leukoc Biol 2011;90(3):413-424.
3. Cavaillon JM. Sir Marc Armand Ruffer and Giulio Bizzozero: the first reports on efferocytosis. J Leukoc Biol Epub 2012 Sep 14.
4. Geissmann F, Gordon S, Hume DA, Mowat AM, Randolph GJ. Unravelling mononuclear phagocyte heterogeneity. Nat Rev Immunol 2010;10(6): 453-460.
5. Gordon S. Elie Metchnikoff: father of natural immunity. Eur J Immunol 2008;38(12):3257-3264.
6. Moberg CL. An appreciation of Ralph Marvin Steinman (1943-2011). J Exp Med 2011;208:2337-2342.
7. Steinman RM, Moberg CL. Zanvil Alexander Cohn 1926-1993. J Exp Med 1994;179(1):1-30.
8. Steinman RM, Cohn ZA. Identification of a novel cell type in peripheral lym-phoid organs of mice. I. Morphology, quantitation, tissue distribution. J Exp Med 1973;137(5):1142-1162.
9. Gordon S. Macrophage heterogeneity and function: biomedical and life sciences collection. London: Henry Stewart Talks Limited, 2012.
10. Nichols BA, Bainton DF. Differentiation of human monocytes in bone marrow and blood. Sequential formation of two granule populations. Lab Invest 1973;29(1):27-40.
11. Braunersreuther V, Zernecke A, Arnaud C, et al. Ccr5 but not Ccr1 deficiency reduces development of diet-induced atherosclerosis in mice. Arterioscler Thromb Vasc Biol 2007;27(2):373-379.
12. Broxmeyer HE, Cooper S, Hangoc G, Gao JL, Murphy PM. Dominant myelo-poietic effector functions mediated by chemokine receptor CCR1. J Exp Med 1999;189(12):1987-1992.
13. Charo IF, Ransohoff RM. The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 2006;354(6):610-621.
14. Eis V, Luckow B, Vielhauer V, et al. Chemokine receptor CCR1 but not CCR5 mediates leukocyte recruitment and subsequent renal fibrosis after unilateral ureteral obstruction. J Am Soc Nephrol 2004;15(2):337-347.
15. Gao JL, Wynn TA, Chang Y, et al. Impaired host defense, hematopoiesis, granulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1. J Exp Med 1997;185(11):1959-1968.
16. Gautier EL, Jakubzick C, Randolph GJ. Regulation of the migration and survival of monocyte subsets by chemokine receptors and its relevance to atherosclerosis. Arterioscler Thromb Vasc Biol 2009;29(10):1412-1418.
17. Gerard C, Frossard JL, Bhatia M, et al. Targeted disruption of the beta-chemokine receptor CCR1 protects against pancreatitis-associated lung injury. J Clin Invest 1997;100(8):2022-2027.
18. Helming L, Gordon S. Molecular mediators of macrophage fusion. Trends Cell Biol 2009;19(10):514-522.
19. Kaufmann A, Salentin R, Gemsa D, Sprenger H. Increase of CCR1 and CCR5 expression and enhanced functional response to MIP-1 alpha during differentiation of human monocytes to macrophages. J Leukoc Biol 2001;69(2):248-252.
20. Leuschner F, Dutta P, Gorbatov R, et al. Therapeutic siRNA silencing in inflammatory monocytes in mice. Nat Biotechnol 2011;29(11):1005-1010.
21. Massberg S, Schaerli P, Knezevic-Maramica I, et al. Immunosurveillance by hematopoietic progenitor cells trafficking through blood, lymph, and peripheral tissues. Cell 2007;131(5):994-1008.
22. Pellegatti P, Falzoni S, Donvito G, Lemaire I, Di Virgilio F. P2X7 receptor drives osteoclast fusion by increasing the extracellular adenosine concentration. FASEB J 2011;25(4):1264-1274.
23. Taylor PR, Martinez-Pomares L, Stacey M, Lin HH, Brown GD, Gordon S. Macrophage receptors and immune recognition. Annu Rev Immunol 2005;23:901-944.
24. Thomas S, Baumgart DC. Targeting leukocyte migration and adhesion in Crohn's disease and ulcerative colitis. Inflammopharmacology 2012;20(1):1-18.
25. Zhang J, Alcaide P, Liu L, et al. Regulation of endothelial cell adhesion molecule expression by mast cells, macrophages, and neutrophils. PLoS One 2011;6(1):e14525.
26. Areschoug T, Plüddemann A, Gordon S. Innate immunity against bacteria. In: Kaufmann SH, Rouse T, Sacks DL, eds. The immune response to infection. Washington, DC: ASM Press, 2011:209-223.
27. Bell JK, Mullen GE, Leifer CA, Mazzoni A, Davies DR, Segal DM. Leucine-rich repeats and pathogen recognition in Toll-like receptors. Trends Immunol 2003;24(10):528-533.
28. Brown GD. Dectin-1: a signalling non-TLR pattern-recognition receptor. Nat Rev Immunol 2006;6(1):33-43.
29. Crocker PR, McMillan SJ, Richards HE. CD33-related siglecs as potential modulators of inflammatory responses. Ann N Y Acad Sci 2012 2012;1253:102-111.
30. Goodridge HS, Reyes CN, Becker CA, et al. Activation of the innate immune receptor Dectin-1 upon formation of a "phagocytic synapse." Nature 2011;472(7344):471-475.
31. Gordon S, Hamann J, Lin HH, Stacey M. F4/80 and the related adhesion-GPCRs. Eur J Immunol 2011;41(9):2472-2476.
32. Janeway CA, Jr., Medzhitov R. Innate immune recognition. Annu Rev Immunol 2002;20:197-216.
33. Kawai T, Akira S. The roles of TLRs, RLRs and NLRs in pathogen recognition. Int Immunol 2009;21(4):317-337.
34. Nakahashi-Oda C, Tahara-Hanaoka S, Shoji M, et al. Apoptotic cells suppress mast cell inflammatory responses via the CD300a immunoreceptor. J Exp Med 2012;209(8):1493-1503.
35. Netea MG, Wijmenga C, O'Neill LA. Genetic variation in Toll-like receptors and disease susceptibility. Nat Immunol 2012;13(6):535-542.
36. Pluddemann A, Mukhopadhyay S, Gordon S. Innate immunity to intracellular pathogens: macrophage receptors and responses to microbial entry. Immunol Rev 2011;240(1):11-24.
37. Trinchieri G, Sher A. Cooperation of Toll-like receptor signals in innate immune defence. Nat Rev Immunol 2007;7(3):179-190.
38. Davis BK, Wen H, Ting JP. The inflammasome NLRs in immunity, inflammation, and associated diseases. Annu Rev Immunol 2011;29:707-735.
39. Jin T, Perry A, Jiang J, et al. Structures of the HIN domain:DNA complexes reveal ligand binding and activation mechanisms of the AIM2 inflammasome and IFI16 receptor. Immunity 2012;36(4):561-571.
40. Khare S, Luc N, Dorfleutner A, Stehlik C. Inflammasomes and their activation. Crit Rev Immunol 2010;30(5):463-487.
41. Strowig T, Henao-Mejia J, Elinav E, Flavell R. Inflammasomes in health and disease. Nature 2012;481(7381):278-286.
42. Conner SD, Schmid SL. Regulated portals of entry into the cell. Nature 2003;422(6927):37-44.
43. Gordon S. Macrophages and phagocytosis. In: Paul WE, ed. Fundamental immunology, 7th ed. Philadelphia, PA: Lippincott, Williams and Wilkins, 2012:547-569.
44. Greenberg S. Diversity in phagocytic signalling. J Cell Sci 2001;114 (Pt 6):1039-1040.
45. Ravichandran KS. Beginnings of a good apoptotic meal: the find-me and eatme signaling pathways. Immunity 2011;35(4):445-455.
46. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 1994;179(4):1109-1118.
47. Savill J, Dransfield I, Gregory C, Haslett C. A blast from the past: clearance of apoptotic cells regulates immune responses. Nat Rev Immunol 2002;2(12):965-975.
48. Stuart LM, Ezekowitz RA. Phagocytosis: elegant complexity. Immunity 2005;22(5):539-550.
49. Alam MM, O'Neill LA. MicroRNAs and the resolution phase of inflammation in macrophages. Eur J Immunol 2011;41(9):2482-2485.
50. Gautier EL, Shay T, Miller J, et al. Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages. Nat Immunol 2012;13(11):1118-1128.
51. Hume DA. Applications of myeloid-specific promoters in transgenic mice support in vivo imaging and functional genomics but do not support the concept of distinct macrophage and dendritic cell lineages or roles in immunity. J Leukoc Biol 2010;89(4):525-538.
52. Miller JC, Brown BD, Shay T, et al. Deciphering the transcriptional network of the dendritic cell lineage. Nat Immunol 2012;13(9):888-899.
53. Kapsenberg ML. Dendritic-cell control of pathogen-driven T-cell polarization. Nat Rev Immunol 2003;3(12):984-993.
54. Trombetta ES, Mellman I. Cell biology of antigen processing in vitro and in vivo. Annu Rev Immunol 2005;23:975-1028.
55. De Leo FR, Ulman KV, Davis AR, Jutila KL, Quinn MT. Assembly of the human neutrophil NADPH oxidase involves binding of p67phox and flavocytochrome b to a common functional domain in p47phox. J Biol Chem 1996;271(29):17013-17020.
56. Dinarello CA. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood 2011;117(14):3720-3732.
57. Evstatiev R, Gasche C. Iron sensing and signalling. Gut 2012;61(6):933-952.
58. Nathan C. Secretory products of macrophages: twenty-five years on. J Clin Invest 2012;122(4):1189-1190.
59. Manderson AP, Kay JG, Hammond LA, Brown DL, Stow JL. Subcompartments of the macrophage recycling endosome direct the differential secretion of IL-6 and TNFA. J. Cell Biol 2007;178:57-69.
60. Banchereau J, Pascual V, O'Garra A. From IL-2 to IL-37: the expanding spectrum of anti-inflammatory cytokines. Nat Immunol 2012;13(10):925-931.
61. Monticelli S, Sallusto F. Negative regulators take center stage. Nat Immunol 2012;13(8):719-720.
62. Murray PJ, Smale ST. Restraint of inflammatory signaling by interdependent strata of negative regulatory pathways. Nat Immunol 2012;13(10):916-924.
63. Cros J, Cagnara N, Woollard K, et al. Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors. Immunity 2010;33(3):375-386.
64. Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat Rev Immunol 2005;5(12):953-964.
65. Heimbeck I, Hofer TP, Eder C, et al. Standardized single-platform assay for human monocyte subpopulations: lower CD14 + CD16 + + monocytes in females. Cytometry A 2010;77(9):823-830.
66. Shi C, Pamer EG. Monocyte recruitment during infection and inflammation. Nat Rev Immunol 2011;11(11):762-774.
67. Ziegler-Heitbrock L, Ancuta P, Crowe S, et al. Nomenclature of monocytes and dendritic cells in blood. Blood 2010;116(16):e74-e80.
68. Egen JG, Rothfuchs AG, Feng CG, Winter N, Sher A, Germain RN. Macrophage and T cell dynamics during the development and disintegration of mycobacterial granulomas. Immunity 2008;28(2):271-284.
69. Gordon S, Martinez FO. Alternative activation of macrophages: mechanism and functions. Immunity 2010;32(5):593-604.
70. Karp CL, Murray PJ. Non-canonical alternatives: what a macrophage is 4. J Exp Med 2012;209(3):427-431.
71. Krausgruber T, Blazek K, Smallie T, et al. IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses. Nat Immunol 2011;12(3):231-238.
72. Lawrence T, Natoli G. Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat Rev Immunol. 2011;11(11):750-761.
73. Satoh T, Takeuchi O, Vandenbon A, et al. The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection. Nat Immunol 2010;11(10):936-944.
74. Martinez FO, Helming L, Milde R, et al. Genetic programs expressed in resting and IL-4 alternatively activated mouse and human macrophages: similarities and differences. Blood. 2013. [Epub ahead of print].
75. Naik SH, Sathe P, Park HY, et al. Development of plasmacytoid and conventional dendritic cell subtypes from single precursor cells derived in vitro and in vivo. Nat Immunol 2007;8(11):1217-1226.
76. Auffray C, Sieweke MH, Geissmann F. Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu Rev Immunol 2009;27:669-692.
77. Sallusto F, Zielinski CE, Lanzavecchia A. Human Th17 subsets. Eur J Immunol 2012;42(9):2215-2220.
78. Chow A, Lucas D, Hidalgo A, et al. Bone marrow CD169+ macrophages promote the retention of hematopoietic stem and progenitor cells in the mesenchymal stem cell niche. J Exp Med 2011;208(2):261-271.
79. Crocker PR, Morris L, Gordon S. Adhesion receptors involved in the erythro-blastic island. Blood Cells 1991;17(1):83-91; discussion 91-86.
80. Crocker PR, Werb Z, Gordon S, Bainton DF. Ultrastructural localization of a macrophage-restricted sialic acid binding hemagglutinin, SER, in macro-phage-hematopoietic cell clusters. Blood 1990;76(6):1131-1138.
81. Lee SH, Crocker PR, Westaby S, et al. Isolation and immunocytochemical characterization of human bone marrow stromal macrophages in hemopoietic clusters. J Exp Med 1988;168(3):1193-1198.
82. Winkler IG, Sims NA, Pettit AR, et al. Bone marrow macrophages maintain hematopoietic stem cell (HSC) niches and their depletion mobilizes HSCs. Blood 2010;116(23):4815-4828.
83. Gray EE, Cyster JG. Lymph node macrophages. J Innate Immun 2012;4 (5-6):424-436.
84. Den Haan JMM, Kraal G. Innate immune functions of macrophage subpopulations in the spleen. J Innate Immun 2012;4(5-6):437-445.
85. Martinez-Pomares L, Gordon S. CD169+ macrophages at the crossroads of antigen presentation. Trends Immunol 2011;33(2):66-70.
86. Martinez-Pomares L, Hanitsch LG, Stillion R, Keshav S, Gordon S. Expression of mannose receptor and ligands for its cysteine-rich domain in venous sinuses of human spleen. Lab Invest 2005;85(10):1238-1249.
87. Steiniger B, Barth P, Herbst B, Hartnell A, Crocker PR. The species-specific structure of microanatomical compartments in the human spleen: strongly sialoadhesin-positive macrophages occur in the perifollicular zone, but not in the marginal zone. Immunology 1997;92(2):307-316.
88. Zaba LC, Fuentes-Duculan J, Steinman RM, Krueger JG, Lowes MA. Normal human dermis contains distinct populations of CD11c+ BDCA-1+ dendritic cells and CD163+ FXIIIA+ macrophages. J Clin Invest 2007;117(9):2517-2525.
89. Haniffa M, Shin A, Bigley V, et al. Human tissues contain CD141hi crosspresenting dendritic cells with functional homology to mouse CD103+ non-lymphoid dendritic cells. Immunity 2012;37(1):60-73.
90. Jaensson E, Uronen-Hansson H, Pabst O, et al. Small intestinal CD103+ dendritic cells display unique functional properties that are conserved between mice and humans. J Exp Med 2008;205(9):2139-2149.
91. Mason R, Austyn J, Brodsky F, Gordon S. Monoclonal antimacrophage antibodies: human pulmonary macrophages express HLA-DR (Ia-like) antigens in culture. Am Rev Respir Dis 1982;125(5):586-593.
92. Wallaert B, Fahy O, Tsicopoulos A, Gosset P, Tonnel AB. Experimental systems for mechanistic studies of toxicant induced lung inflammation. Toxicol Lett 2000;112-113:157-163.
93. Kennedy DW, Abkowitz JL. Kinetics of central nervous system microglial and macrophage engraftment: analysis using a transgenic bone marrow transplantation model. Blood 1997;90(3):986-993.
94. Wang Y, Szretter KJ, Vermi W, et al. IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microglia. Nat Immunol 2012;13(8):753-760.
95. de Witte L, Nabatov A, Pion M, et al. Langerin is a natural barrier to HIV-1 transmission by Langerhans cells. Nat Med 2007;13(3):367-371.
96. Klechevsky E, Morita R, Liu M, et al. Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells. Immunity 2008;29(3):497-510.
97. Lenz A, Heine M, Schuler G, Romani N. Human and murine dermis contain dendritic cells. Isolation by means of a novel method and phenotypical and functional characterization. J Clin Invest 1993;92(6):2587-2596.
98. Mc Dermott R, Ziylan U, Spehner D, et al. Birbeck granules are subdomains of endosomal recycling compartment in human epidermal Langerhans cells, which form where langerin accumulates. Mol Biol Cell 2002;13(1):317-335.
99. Nestle FO, Zheng XG, Thompson CB, Turka LA, Nickoloff BJ. Characterization of dermal dendritic cells obtained from normal human skin reveals phenotypic and functionally distinctive subsets. J Immunol 1993;151(11): 6535-6545.
100. Romani N, Clausen BE, Stoitzner P. Langerhans cells and more: langerin-expressing dendritic cell subsets in the skin. Immunol Rev 2010;234(1): 120-141.
101. Romani N, Ebner S, Flacher V, et al., eds. Langerhans cells-dendritic cells of the epidermis and other epithelia. In: Saeland S, ed. Recent advances in skin immunology. Research Signpost, Kerala, India, 2008:27.
102. Athanasou NA. The osteoclast-what's new? Skeletal Radiol 2011;40(9): 1137-1140.
103. Athanasou NA, Quinn J. Immunophenotypic differences between osteoclasts and macrophage polykaryons: immunohistological distinction and implications for osteoclast ontogeny and function. J Clin Pathol 1990;43(12):997-1003.
104. Miyamoto T. Regulators of osteoclast differentiation and cell-cell fusion. Keio J Med 2011;60(4):101-105.
105. Vaananen HK, Laitala-Leinonen T. Osteoclast lineage and function. Arch Biochem Biophys 2008;473(2):132-138.
106. Woollard KJ, Geissmann F. Monocytes in atherosclerosis: subsets and functions. Nat Rev Cardiol 2010;7(2):77-86.
107. Ginhoux F, Greter M, Leboeuf M, et al. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 2010;330(6005):841-845.
108. Schuster C, Vaculik C, Fiala C, et al. HLA-DR+ leukocytes acquire CD1 antigens in embryonic and fetal human skin and contain functional antigen-presenting cells. J Exp Med 2009;206(1):169-181.
109. Bigley V, Haniffa M, Doulatov S, et al. The human syndrome of dendritic cell, monocyte, B and NK lymphoid deficiency. J Exp Med 2011;208(2):227-234.
110. Collin MP, Hart DN, Jackson GH, et al. The fate of human Langerhans cells in hematopoietic stem cell transplantation. J Exp Med 2006;203(1):27-33.
111. Hambleton S, Salem S, Bustamante J, et al. IRF8 mutations and human dendritic-cell immunodeficiency. N Engl J Med 2011;365(2):127-138.
112. Haniffa M, Ginhoux F, Wang XN, et al. Differential rates of replacement of human dermal dendritic cells and macrophages during hematopoietic stem cell transplantation. J Exp Med 2009;206(2):371-385.
113. Merad M, Manz MG, Karsunky H, et al. Langerhans cells renew in the skin throughout life under steady-state conditions. Nat Immunol 2002;3(12): 1135-1141.
114. Doulatov S, Notta F, Laurenti E, Dick JE. Hematopoiesis: a human perspective. Cell Stem Cell 2012;10(2):120-136.
115. Fogg DK, Sibon C, Miled C, et al. A clonogenic bone marrow progenitor specific for macrophages and dendritic cells. Science 2006;311(5757):83-87.
116. Geissmann F, Manz MG, Jung S, Sieweke MH, Merad M, Ley K. Development of monocytes, macrophages, and dendritic cells. Science 2010;327(5966):656-661.
117. Novershtern N, Subramanian A, Lawton LN, et al. Densely interconnected transcriptional circuits control cell states in human hematopoiesis. Cell 2011;144(2):296-309.
118. Greter M, Helft J, Chow A, et al. GM-CSF controls nonlymphoid tissue dendritic cell homeostasis but is dispensable for the differentiation of inflammatory dendritic cells. Immunity 2012;36(6):1031-1046.
119. Collin M, Bigley V, Haniffa M, Hambleton S. Human dendritic cell deficiency: the missing ID? Nat Rev Immunol 2011;11(9):575-583.
120. Meredith MM, Liu K, Kamphorst AO, et al. Zinc finger transcription factor zDC is a negative regulator required to prevent activation of classical dendritic cells in the steady state. J Exp Med 2012;209(9):1583-1593.
121. Schulz C, Gomez Perdiguero E, Chorro L, et al. A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science 2012 2012;336(6077):86-90.
122. Qi F, Adair A, Ferenbach D, et al. Depletion of cells of monocyte lineage prevents loss of renal microvasculature in murine kidney transplantation. Transplantation 2008;86(9):1267-1274.
123. Badalian-Very G, Vergilio JA, Fleming M, Rollins BJ. Pathogenesis of Langerhans cell histiocytosis. Annu Rev Pathol Epub 2012 Aug 6.
124. Risma K, Jordan MB. Hemophagocytic lymphohistiocytosis: updates and evolving concepts. Curr Opin Pediatr 2012;24(1):9-15.
125. Pastores GM, Weinreb NJ, Aerts H, et al. Therapeutic goals in the treatment of Gaucher disease. Semin Hematol 2004;41(4 Suppl 5):4-14.
126. Panicker LM, Miller D, Park TS, et al. Induced pluripotent stem cell model recapitulates pathologic hallmarks of Gaucher disease. Proc Natl Acad Sci U S A 2012;109(44):18054-18059.
127. Ganz T. Macrophages and systemic iron homeostasis. J Innate Immun 2012;4(5-6):446-453.
128. Jacolot S, Yang Y, Paitry P, Ferec C, Mura C. Iron metabolism in macrophages from HFE hemochromatosis patients. Mol Genet Metab 2010;101(2-3):258-267.
129. Pietrangelo A, Caleffi A, Corradini E. Non-HFE hepatic iron overload. Semin Liver Dis 2011;31(3):302-318.
130. Lacey DL, Boyle WJ, Simonet WS, et al. Bench to bedside: elucidation of the OPG-RANK-RANKL pathway and the development of denosumab. Nat Rev Drug Discov 2012;11(5):401-419.
131. Michou L, Brown JP. Genetics of bone diseases: Paget's disease, fibrous dysplasia, osteopetrosis, and osteogenesis imperfecta. Joint Bone Spine 2011;78(3):252-258.
132. Coxon FP, Taylor A. Vesicular trafficking in osteoclasts. Semin Cell Dev Biol 2008;19(5):424-433.
133. Kalinski P, Edington H, Zeh HJ, et al. Dendritic cells in cancer immunotherapy: vaccines or autologous transplants? Immunol Res 2011;50(2-3):235-247.
134. Gordon S, Cohn Z. Macrophage-melanocyte heterokaryons. I. Preparation and properties. J Exp Med 1970;131(5):981-1003.
135. Gordon S. Alternative activation of macrophages. Nat Rev Immunol 2003;3(1):23-35.